Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Endosonics(eson) -- Ignore unavailable to you. Want to Upgrade?

To: Sam Quentin who wrote (120)	3/7/1998 5:09:00 PM
From: pollira	Respond to of 205

i don't see how they are related at all. esti is developing a percutaneous transmyocardial revascularization technique (in english, you thread a catheter into the heart, and shoot holes in the heart muscle with a laser, supposed to improve vascularization / blood flow into areas of heart that have poor blood flow). Eson makes a diagnostic device, which images the interior of coronary arteries. The Esti device was tested as an adjunct to bypass surgery. I suppose if the TMR improves the results of bypass surgery as much as is claimed, then more people would be in line to get angiograms, which could possibly increase use of Eson's device. On the other hand, the main use of eson's device would appear to be as an aid in reaming out coronary arteries, so that you can avoid bypass surgery. if TMR improves bypass surgery to the point that balloons, stents, and intracoronary lasers are less effective, then Eson would have trouble. all told, hard to predict any relation between the two companies. Ira

To: Sam Quentin who wrote (120)	3/9/1998 6:53:00 AM
From: Asymmetric	Read Replies (1) \| Respond to of 205

Sam, Institutions are Selling This Stock I ran a recent check on FreeEdgar of 13G's. This url shows some of the bigger institutional positions in July 1997. Message 1734355 In contrast: 2/17/98 - Wells Fargo 11,400 2/12/98 - Scudder Kemper 0 2/06/98 - Dresdner Bank 0 1/23/98 - Putnam Investment 0 And the mighty Chancellor LGT Management listed 2/06/98 - 3,713,300 shares (23.0%) 2/09/98 - 3,312,900 shares (20.5%) Guess even though Insider recommended the stock based on insider buying pattern (my guess as I don't subscribe or know their methodology) you still have to check that against what the institutions are doing. Please note I also sold all my shares last week. Good luck to all. Peter.